C Partners Holding Gmb H United Therapeutics Corp Transaction History

C Partners Holding Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$101.4 - $128.73 $98,256 - $124,739	-969 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$113.81 - $129.46 $117,224 - $133,343	-1,030 Reduced 51.53%	969 $124,000
Q2 2018 Aug 14, 2018	BUY	$101.14 - $118.31 $27,510 - $32,180	272 Added 15.75%	1,999 $226,000
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $52,211 - $73,994	-487 Reduced 22.0%	1,727 $194,000
Q4 2017 Feb 14, 2018	BUY	$118.58 - $151.28 $262,536 - $334,933	2,214	2,214 $328,000

679

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of C Partners Holding Gmb H, based on Form 13F filings with the SEC.

Stay updated on C Partners Holding Gmb H with notifications on news.